Human liver nicotinamide N-methyltransferase: Ion-pairing radiochemical assay, biochemical properties and individual variation

Josephine Rini, Carol Szumlanski, Roberto Guerciolini, Richard M Weinshilboum

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of nicotinamide, pyridine, and structurally related compounds. The products of this reaction are positively charged pyridinium ions that cannot be removed from aqueous solution by simple organic solvent extraction. We developed an assay for human liver NNMT based on the extraction of the positively charged reaction product into 60% isoamyl alcohol in toluene in the presence of the ion-pairing reagent 1-heptanesulfonic acid. Nicotinamide was the methyl acceptor for the reaction, and [14C-methyl]-S-adenosyl-l-methionine (Ado-Met) served as the methyl donor. Apparent Km values of human liver NNMT for nicotinamide and Ado-Met were 347 and 1.76 μmol/l, respectively. The product of the reaction was identified as N1-methylnicotinamide (NMN) by high performance liquid chromatography. NNMT activity was inhibited by the reaction products, NMN and S-adenosyl-l-homocysteine. NNMT activity was not affected by inhibitors of other methyltransferases including Ca2+, SKF 525A and 3,4-dimethoxy-5-hydroxybenzoic acid. Individual variation in NNMT activity was studied by measuring hepatic enzyme activities in 163 human liver biopsy samples obtained during clinically-indicated surgery. The average NNMT activity in these samples was 51.5 ± 32.5 U per mg protein (mean ± SD), and there was not a significant correlation of enzyme activity with patient age or with the time of storage of the biopsy samples at -80°C. The distribution of activities was bimodal, and approximately 26% of the samples were included in a subgroup with high NNMT activity. It will now be possible to test the hypothesis that individual differences in hepatic NNMT activity might be related to variation in the N-methylation of pyridine compounds and to individual differences in either toxicity or the therapeutic efficacy of such compounds.

Original languageEnglish (US)
Pages (from-to)359-374
Number of pages16
JournalClinica Chimica Acta
Volume186
Issue number3
DOIs
StatePublished - Jan 31 1990

Fingerprint

Nicotinamide N-Methyltransferase
Liver
Assays
Ions
Niacinamide
Individuality
Methionine
Methylation
Biopsy
Enzyme activity
Reaction products
Proadifen
Methyltransferases
Toluene
Homocysteine
Enzymes
human NNMT protein
High performance liquid chromatography
Solvent extraction
High Pressure Liquid Chromatography

Keywords

  • Ion-pairing
  • Liver enzyme
  • Methyl conjugation
  • Nicotinamide N-methyltransferase
  • Pyridinium ion

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Human liver nicotinamide N-methyltransferase : Ion-pairing radiochemical assay, biochemical properties and individual variation. / Rini, Josephine; Szumlanski, Carol; Guerciolini, Roberto; Weinshilboum, Richard M.

In: Clinica Chimica Acta, Vol. 186, No. 3, 31.01.1990, p. 359-374.

Research output: Contribution to journalArticle

@article{d0722132e0a8404c82e6e67a7e0b3ddc,
title = "Human liver nicotinamide N-methyltransferase: Ion-pairing radiochemical assay, biochemical properties and individual variation",
abstract = "Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of nicotinamide, pyridine, and structurally related compounds. The products of this reaction are positively charged pyridinium ions that cannot be removed from aqueous solution by simple organic solvent extraction. We developed an assay for human liver NNMT based on the extraction of the positively charged reaction product into 60{\%} isoamyl alcohol in toluene in the presence of the ion-pairing reagent 1-heptanesulfonic acid. Nicotinamide was the methyl acceptor for the reaction, and [14C-methyl]-S-adenosyl-l-methionine (Ado-Met) served as the methyl donor. Apparent Km values of human liver NNMT for nicotinamide and Ado-Met were 347 and 1.76 μmol/l, respectively. The product of the reaction was identified as N1-methylnicotinamide (NMN) by high performance liquid chromatography. NNMT activity was inhibited by the reaction products, NMN and S-adenosyl-l-homocysteine. NNMT activity was not affected by inhibitors of other methyltransferases including Ca2+, SKF 525A and 3,4-dimethoxy-5-hydroxybenzoic acid. Individual variation in NNMT activity was studied by measuring hepatic enzyme activities in 163 human liver biopsy samples obtained during clinically-indicated surgery. The average NNMT activity in these samples was 51.5 ± 32.5 U per mg protein (mean ± SD), and there was not a significant correlation of enzyme activity with patient age or with the time of storage of the biopsy samples at -80°C. The distribution of activities was bimodal, and approximately 26{\%} of the samples were included in a subgroup with high NNMT activity. It will now be possible to test the hypothesis that individual differences in hepatic NNMT activity might be related to variation in the N-methylation of pyridine compounds and to individual differences in either toxicity or the therapeutic efficacy of such compounds.",
keywords = "Ion-pairing, Liver enzyme, Methyl conjugation, Nicotinamide N-methyltransferase, Pyridinium ion",
author = "Josephine Rini and Carol Szumlanski and Roberto Guerciolini and Weinshilboum, {Richard M}",
year = "1990",
month = "1",
day = "31",
doi = "10.1016/0009-8981(90)90322-J",
language = "English (US)",
volume = "186",
pages = "359--374",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Human liver nicotinamide N-methyltransferase

T2 - Ion-pairing radiochemical assay, biochemical properties and individual variation

AU - Rini, Josephine

AU - Szumlanski, Carol

AU - Guerciolini, Roberto

AU - Weinshilboum, Richard M

PY - 1990/1/31

Y1 - 1990/1/31

N2 - Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of nicotinamide, pyridine, and structurally related compounds. The products of this reaction are positively charged pyridinium ions that cannot be removed from aqueous solution by simple organic solvent extraction. We developed an assay for human liver NNMT based on the extraction of the positively charged reaction product into 60% isoamyl alcohol in toluene in the presence of the ion-pairing reagent 1-heptanesulfonic acid. Nicotinamide was the methyl acceptor for the reaction, and [14C-methyl]-S-adenosyl-l-methionine (Ado-Met) served as the methyl donor. Apparent Km values of human liver NNMT for nicotinamide and Ado-Met were 347 and 1.76 μmol/l, respectively. The product of the reaction was identified as N1-methylnicotinamide (NMN) by high performance liquid chromatography. NNMT activity was inhibited by the reaction products, NMN and S-adenosyl-l-homocysteine. NNMT activity was not affected by inhibitors of other methyltransferases including Ca2+, SKF 525A and 3,4-dimethoxy-5-hydroxybenzoic acid. Individual variation in NNMT activity was studied by measuring hepatic enzyme activities in 163 human liver biopsy samples obtained during clinically-indicated surgery. The average NNMT activity in these samples was 51.5 ± 32.5 U per mg protein (mean ± SD), and there was not a significant correlation of enzyme activity with patient age or with the time of storage of the biopsy samples at -80°C. The distribution of activities was bimodal, and approximately 26% of the samples were included in a subgroup with high NNMT activity. It will now be possible to test the hypothesis that individual differences in hepatic NNMT activity might be related to variation in the N-methylation of pyridine compounds and to individual differences in either toxicity or the therapeutic efficacy of such compounds.

AB - Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of nicotinamide, pyridine, and structurally related compounds. The products of this reaction are positively charged pyridinium ions that cannot be removed from aqueous solution by simple organic solvent extraction. We developed an assay for human liver NNMT based on the extraction of the positively charged reaction product into 60% isoamyl alcohol in toluene in the presence of the ion-pairing reagent 1-heptanesulfonic acid. Nicotinamide was the methyl acceptor for the reaction, and [14C-methyl]-S-adenosyl-l-methionine (Ado-Met) served as the methyl donor. Apparent Km values of human liver NNMT for nicotinamide and Ado-Met were 347 and 1.76 μmol/l, respectively. The product of the reaction was identified as N1-methylnicotinamide (NMN) by high performance liquid chromatography. NNMT activity was inhibited by the reaction products, NMN and S-adenosyl-l-homocysteine. NNMT activity was not affected by inhibitors of other methyltransferases including Ca2+, SKF 525A and 3,4-dimethoxy-5-hydroxybenzoic acid. Individual variation in NNMT activity was studied by measuring hepatic enzyme activities in 163 human liver biopsy samples obtained during clinically-indicated surgery. The average NNMT activity in these samples was 51.5 ± 32.5 U per mg protein (mean ± SD), and there was not a significant correlation of enzyme activity with patient age or with the time of storage of the biopsy samples at -80°C. The distribution of activities was bimodal, and approximately 26% of the samples were included in a subgroup with high NNMT activity. It will now be possible to test the hypothesis that individual differences in hepatic NNMT activity might be related to variation in the N-methylation of pyridine compounds and to individual differences in either toxicity or the therapeutic efficacy of such compounds.

KW - Ion-pairing

KW - Liver enzyme

KW - Methyl conjugation

KW - Nicotinamide N-methyltransferase

KW - Pyridinium ion

UR - http://www.scopus.com/inward/record.url?scp=0025058295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025058295&partnerID=8YFLogxK

U2 - 10.1016/0009-8981(90)90322-J

DO - 10.1016/0009-8981(90)90322-J

M3 - Article

C2 - 2311261

AN - SCOPUS:0025058295

VL - 186

SP - 359

EP - 374

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 3

ER -